| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |